Robert Rosen
CIK 1555089 · President · last filed 2022-08-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$42.2K
Companies
3
Total Filings
26
Lifetime Open-Market Net
-$15.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | — | $6.22 | — | $0 | 9 | 2022-01-14 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | — | $1.12 | — | $0 | 4 | 2020-12-10 |
| HRTX | President | 98,171 | $0.43 | $42.2K | -$15.75M | 8 | 2018-12-18 |
Recent Filings · Page 2 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-04 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-20 | HRTX | Grant (A) | — | $0 | EDGAR |
| 2017-12-13 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-23 | HRTX | Grant (A) | — | $0 | EDGAR |
| 2016-08-12 | HRTX | Mixed | — | -$1.61M | EDGAR |
| 2016-04-21 | HRTX | Mixed | — | -$3.21M | EDGAR |
| 2015-12-24 | HRTX | Grant (A) | — | $0 | EDGAR |
| 2015-12-23 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-25 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.